First person: John Byrd, MD: This Ohio State University researcher has been developing transformative treatments for patients with chronic lymphocytic leukemia, and now is setting his sights on individuals with acute myeloid leukemia

Cancer. 2018 May 15;124(10):2069. doi: 10.1002/cncr.31512.
No abstract available

Publication types

  • Biography
  • Historical Article

MeSH terms

  • Awards and Prizes
  • Biomedical Research / history
  • Faculty, Medical
  • Hematology / history
  • History, 20th Century
  • History, 21st Century
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
  • Leukemia, Myeloid, Acute / therapy*
  • Male
  • Medical Oncology / history
  • Ohio
  • Oncologists / history*
  • Research Personnel / history*
  • Universities

Personal name as subject

  • John Byrd